Zealand Pharma A/S (ZLDPF)
35.64
-1.90
(-5.05%)
USD |
OTCM |
Oct 09, 16:00
Zealand Pharma Cash from Investing (Quarterly) : 34.81M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.81M |
| March 31, 2026 | -18.17M |
| December 31, 2025 | -56.83M |
| September 30, 2025 | -138.71M |
| June 30, 2025 | -233.14M |
| March 31, 2025 | 78.25M |
| December 31, 2024 | 53.25M |
| September 30, 2024 | -894.48M |
| June 30, 2024 | -4.391M |
| March 31, 2024 | -200.66M |
| December 31, 2023 | 0.9658M |
| September 30, 2023 | 23.38M |
| June 30, 2023 | -174.73M |
| March 31, 2023 | -9.348M |
| December 31, 2022 | 14.08M |
| September 30, 2022 | 10.44M |
| June 30, 2022 | -29.84M |
| March 31, 2022 | 44.36M |
| December 31, 2021 | -1.793M |
| September 30, 2021 | -0.3355M |
| June 30, 2021 | 0.1259M |
| March 31, 2021 | -0.7819M |
| December 31, 2020 | 0.6394M |
| September 30, 2020 | -2.256M |
| June 30, 2020 | -24.77M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.757M |
| December 31, 2019 | -0.6061M |
| September 30, 2019 | -2.771M |
| June 30, 2019 | -0.0274M |
| March 31, 2019 | -4.514M |
| December 31, 2018 | -72.22M |
| September 30, 2018 | 211.53M |
| June 30, 2018 | -0.1604M |
| March 31, 2018 | -0.0959M |
| December 31, 2017 | -13.73M |
| September 30, 2017 | 2.796M |
| June 30, 2017 | 1.465M |
| March 31, 2017 | 44.48M |
| December 31, 2016 | 19.58M |
| September 30, 2016 | -3.299M |
| June 30, 2016 | -4.017M |
| March 31, 2016 | -13.35M |
| December 31, 2015 | -0.1108M |
| September 30, 2015 | -0.2239M |
| June 30, 2015 | -0.2016M |
| March 31, 2015 | -0.0596M |
| December 31, 2014 | -0.2723M |
| September 30, 2014 | -0.1577M |
| June 30, 2014 | -0.0649M |
| March 31, 2014 | 4.154M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Genmab A/S | 2.026M |
| Ascendis Pharma A/S | -3.268M |
| Bavarian Nordic A/S | -5.386M |
| Evaxion AS | -- |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 63.85M |
| Cash from Financing (Quarterly) | -67.67M |
| Free Cash Flow | -253.76M |
| Free Cash Flow Per Share (Quarterly) | 0.8715 |
| Free Cash Flow to Equity (Quarterly) | 62.66M |
| Free Cash Flow to Firm (Quarterly) | 63.51M |
| Free Cash Flow Yield | -10.09% |